Bank Of Montreal Kymera Therapeutics, Inc. Transaction History

Bank Of Montreal

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$14.13 - $42.55 $838,898 - $2.53 Million	59,370 New	59,370 $1.18 Million
Q4 2021 Feb 11, 2022	SELL	$49.91 - $65.56 $8.69 Million - $11.4 Million	-174,027 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$47.8 - $66.66 $8.32 Million - $11.6 Million	174,027 New	174,027 $10.2 Million

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.3B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.